Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Synaptic biomarker reduction and impaired cognition in the sub-chronic PCP mouse model for schizophrenia.

Gigg J, McEwan F, Smausz R, Neill J, Harte MK.

J Psychopharmacol. 2019 Oct 3:269881119874446. doi: 10.1177/0269881119874446. [Epub ahead of print]

PMID:
31580184
2.

Global brain volume reductions in a sub-chronic phencyclidine animal model for schizophrenia and their relationship to recognition memory.

Doostdar N, Kim E, Grayson B, Harte MK, Neill JC, Vernon AC.

J Psychopharmacol. 2019 Oct;33(10):1274-1287. doi: 10.1177/0269881119844196. Epub 2019 May 7.

PMID:
31060435
3.

Adjunctive Lurasidone Suppresses Food Intake and Weight Gain Associated with Olanzapine Administration in Rats.

Reynolds GP, Dalton CF, Watrimez W, Jackson J, Harte MK.

Clin Psychopharmacol Neurosci. 2019 May 31;17(2):314-317. doi: 10.9758/cpn.2019.17.2.314.

4.

Evolution of a maternal immune activation (mIA) model in rats: Early developmental effects.

Murray KN, Edye ME, Manca M, Vernon AC, Oladipo JM, Fasolino V, Harte MK, Mason V, Grayson B, McHugh PC, Knuesel I, Prinssen EP, Hager R, Neill JC.

Brain Behav Immun. 2019 Jan;75:48-59. doi: 10.1016/j.bbi.2018.09.005. Epub 2018 Sep 12.

PMID:
30218784
5.

Stabilized Low-n Amyloid-β Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.

Watremez W, Jackson J, Almari B, McLean SL, Grayson B, Neill JC, Fischer N, Allouche A, Koziel V, Pillot T, Harte MK.

J Alzheimers Dis. 2018;62(1):213-226. doi: 10.3233/JAD-170489.

PMID:
29439327
6.

NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update.

Cadinu D, Grayson B, Podda G, Harte MK, Doostdar N, Neill JC.

Neuropharmacology. 2018 Nov;142:41-62. doi: 10.1016/j.neuropharm.2017.11.045. Epub 2017 Nov 28. Review.

PMID:
29196183
7.

Boron-Based Inhibitors of the NLRP3 Inflammasome.

Baldwin AG, Rivers-Auty J, Daniels MJD, White CS, Schwalbe CH, Schilling T, Hammadi H, Jaiyong P, Spencer NG, England H, Luheshi NM, Kadirvel M, Lawrence CB, Rothwell NJ, Harte MK, Bryce RA, Allan SM, Eder C, Freeman S, Brough D.

Cell Chem Biol. 2017 Nov 16;24(11):1321-1335.e5. doi: 10.1016/j.chembiol.2017.08.011. Epub 2017 Sep 21.

8.

Dopamine dysregulation in the prefrontal cortex relates to cognitive deficits in the sub-chronic PCP-model for schizophrenia: A preliminary investigation.

McLean SL, Harte MK, Neill JC, Young AM.

J Psychopharmacol. 2017 Jun;31(6):660-666. doi: 10.1177/0269881117704988. Epub 2017 Apr 26.

PMID:
28441905
9.

Subchronic administration of phencyclidine produces hypermethylation in the parvalbumin gene promoter in rat brain.

Fachim HA, Srisawat U, Dalton CF, Harte MK, Marsh S, Neill JC, Reynolds GP.

Epigenomics. 2016 Sep;8(9):1179-83. doi: 10.2217/epi-2016-0050. Epub 2016 Aug 16.

PMID:
27529801
10.

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.

Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, Booth SJ, White CS, Baldwin AG, Freeman S, Wong R, Latta C, Yu S, Jackson J, Fischer N, Koziel V, Pillot T, Bagnall J, Allan SM, Paszek P, Galea J, Harte MK, Eder C, Lawrence CB, Brough D.

Nat Commun. 2016 Aug 11;7:12504. doi: 10.1038/ncomms12504.

11.

Nicotinic α7 and α4β2 agonists enhance the formation and retrieval of recognition memory: Potential mechanisms for cognitive performance enhancement in neurological and psychiatric disorders.

McLean SL, Grayson B, Marsh S, Zarroug SH, Harte MK, Neill JC.

Behav Brain Res. 2016 Apr 1;302:73-80. doi: 10.1016/j.bbr.2015.08.037. Epub 2015 Aug 30.

PMID:
26327238
12.

Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

Barnes SA, Sawiak SJ, Caprioli D, Jupp B, Buonincontri G, Mar AC, Harte MK, Fletcher PC, Robbins TW, Neill JC, Dalley JW.

Int J Neuropsychopharmacol. 2014 Oct 31;18(2). pii: pyu010. doi: 10.1093/ijnp/pyu010.

13.

Deletion of α-neurexin II results in autism-related behaviors in mice.

Dachtler J, Glasper J, Cohen RN, Ivorra JL, Swiffen DJ, Jackson AJ, Harte MK, Rodgers RJ, Clapcote SJ.

Transl Psychiatry. 2014 Nov 25;4:e484. doi: 10.1038/tp.2014.123.

14.

Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.

Tomlinson A, Grayson B, Marsh S, Harte MK, Barnes SA, Marshall KM, Neill JC.

Eur Neuropsychopharmacol. 2014 Aug;24(8):1371-80. doi: 10.1016/j.euroneuro.2014.04.008. Epub 2014 May 2.

PMID:
24882551
15.

Acute and chronic effects of NMDA receptor antagonists in rodents, relevance to negative symptoms of schizophrenia: a translational link to humans.

Neill JC, Harte MK, Haddad PM, Lydall ES, Dwyer DM.

Eur Neuropsychopharmacol. 2014 May;24(5):822-35. doi: 10.1016/j.euroneuro.2013.09.011. Epub 2013 Oct 12. Review.

PMID:
24287012
16.

First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK.

Saleem MM, Harte MK, Marshall KM, Scally A, Brewin A, Neill JC.

J Psychopharmacol. 2013 Apr;27(4):366-73. doi: 10.1177/0269881113477746. Epub 2013 Feb 20.

PMID:
23427189
17.

Animal models of cognitive dysfunction and negative symptoms of schizophrenia: focus on NMDA receptor antagonism.

Neill JC, Barnes S, Cook S, Grayson B, Idris NF, McLean SL, Snigdha S, Rajagopal L, Harte MK.

Pharmacol Ther. 2010 Dec;128(3):419-32. doi: 10.1016/j.pharmthera.2010.07.004. Epub 2010 Aug 10. Review.

PMID:
20705091
18.

Clorgyline-mediated reversal of neurological deficits in a Complexin 2 knockout mouse.

Glynn D, Gibson HE, Harte MK, Reim K, Jones S, Reynolds GP, Morton AJ.

Hum Mol Genet. 2010 Sep 1;19(17):3402-12. doi: 10.1093/hmg/ddq252. Epub 2010 Jun 28.

PMID:
20584925
19.

Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.

Jenkins TA, Harte MK, Reynolds GP.

Neurosci Lett. 2010 Mar 8;471(3):144-7. doi: 10.1016/j.neulet.2010.01.028. Epub 2010 Jan 25.

PMID:
20097262
20.

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.

McKibben CE, Jenkins TA, Adams HN, Harte MK, Reynolds GP.

Behav Brain Res. 2010 Mar 17;208(1):132-6. doi: 10.1016/j.bbr.2009.11.018. Epub 2009 Nov 13.

PMID:
19914297
21.

Neonatal lipopolysaccharide induces pathological changes in parvalbumin immunoreactivity in the hippocampus of the rat.

Jenkins TA, Harte MK, Stenson G, Reynolds GP.

Behav Brain Res. 2009 Dec 28;205(2):355-9. doi: 10.1016/j.bbr.2009.07.014. Epub 2009 Jul 22.

PMID:
19631237
22.

Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.

Jenkins TA, Harte MK, McKibben CE, Elliott JJ, Reynolds GP.

Behav Brain Res. 2008 Dec 12;194(2):230-5. doi: 10.1016/j.bbr.2008.07.020. Epub 2008 Jul 25.

PMID:
18706451
23.

Deficits of neuronal glutamatergic markers in the caudate nucleus in schizophrenia.

Nudmamud-Thanoi S, Piyabhan P, Harte MK, Cahir M, Reynolds GP.

J Neural Transm Suppl. 2007;(72):281-5.

PMID:
17982904
24.

Deficits in parvalbumin and calbindin immunoreactive cells in the hippocampus of isolation reared rats.

Harte MK, Powell SB, Swerdlow NR, Geyer MA, Reynolds GP.

J Neural Transm (Vienna). 2007 Jul;114(7):893-8. Epub 2007 Feb 15.

PMID:
17594127
25.

Sub-chronic phencyclidine administration increases brain-derived neurotrophic factor in the RAT hippocampus.

Harte MK, Cahir M, Reynolds GP, Gartlon JE, Jones DN.

Schizophr Res. 2007 Aug;94(1-3):371-2. Epub 2007 Jun 8. No abstract available.

PMID:
17560767
26.

The neuronal pathology of schizophrenia: molecules and mechanisms.

Reynolds GP, Harte MK.

Biochem Soc Trans. 2007 Apr;35(Pt 2):433-6.

PMID:
17371293
27.

Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol.

Harte MK, Bachus SB, Reynolds GP.

Schizophr Res. 2005 Jun 15;75(2-3):303-8. Epub 2004 Dec 1.

PMID:
15885521
28.

Reduced N-acetylaspartate in the temporal cortex of rats reared in isolation.

Harte MK, Powell SB, Reynolds LM, Swerdlow NR, Geyer MA, Reynolds GP.

Biol Psychiatry. 2004 Aug 15;56(4):296-9.

PMID:
15312819
29.

Metabotropic glutamate mGlu5 receptor-mediated modulation of the ventral striopallidal GABA pathway in rats. Interactions with adenosine A(2A) and dopamine D(2) receptors.

Díaz-Cabiale Z, Vivó M, Del Arco A, O'Connor WT, Harte MK, Müller CE, Martínez E, Popoli P, Fuxe K, Ferré S.

Neurosci Lett. 2002 May 17;324(2):154-8.

PMID:
11988350

Supplemental Content

Loading ...
Support Center